President Trump announced potential tariffs on pharmaceutical imports reaching up to 250 percent, targeting countries allegedly tied to Russia. The move is part of a broader economic retaliation strategy involving semiconductors and other sectors. Trading partners like Switzerland quickly proposed alternative settlement offers. Markets responded with volatility though optimism about Fed rate cuts and strong corporate earnings persisted. Analysts warn increased trade tensions may upset supply chains and investor confidence.